EP1567655A2 - Production enzymatique de derives de flavonoides acyles - Google Patents
Production enzymatique de derives de flavonoides acylesInfo
- Publication number
- EP1567655A2 EP1567655A2 EP03812154A EP03812154A EP1567655A2 EP 1567655 A2 EP1567655 A2 EP 1567655A2 EP 03812154 A EP03812154 A EP 03812154A EP 03812154 A EP03812154 A EP 03812154A EP 1567655 A2 EP1567655 A2 EP 1567655A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- flavonoid
- reaction
- acyl donor
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 acyl flavonoid derivatives Chemical class 0.000 title claims abstract description 28
- 230000002255 enzymatic effect Effects 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title description 4
- 229930003935 flavonoid Natural products 0.000 claims abstract description 87
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 87
- 238000006243 chemical reaction Methods 0.000 claims abstract description 78
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 71
- 125000002252 acyl group Chemical group 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 50
- 239000002904 solvent Substances 0.000 claims abstract description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000012429 reaction media Substances 0.000 claims abstract description 22
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 19
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- 150000002148 esters Chemical class 0.000 claims abstract description 5
- 239000002245 particle Substances 0.000 claims abstract description 4
- 239000002808 molecular sieve Substances 0.000 claims description 24
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 19
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 16
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 10
- 108090001060 Lipase Proteins 0.000 claims description 9
- 102000004882 Lipase Human genes 0.000 claims description 9
- 239000004367 Lipase Substances 0.000 claims description 9
- 235000019421 lipase Nutrition 0.000 claims description 9
- 235000021314 Palmitic acid Nutrition 0.000 claims description 8
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 8
- QQHJDPROMQRDLA-UHFFFAOYSA-N hexadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCC(O)=O QQHJDPROMQRDLA-UHFFFAOYSA-N 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 8
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 8
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 5
- 238000007792 addition Methods 0.000 claims description 5
- 238000005194 fractionation Methods 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- UGAGPNKCDRTDHP-UHFFFAOYSA-N 16-hydroxyhexadecanoic acid Chemical compound OCCCCCCCCCCCCCCCC(O)=O UGAGPNKCDRTDHP-UHFFFAOYSA-N 0.000 claims description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 4
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 claims description 4
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- GWOLZNVIRIHJHB-UHFFFAOYSA-N 11-mercaptoundecanoic acid Chemical compound OC(=O)CCCCCCCCCCS GWOLZNVIRIHJHB-UHFFFAOYSA-N 0.000 claims description 3
- 229940114072 12-hydroxystearic acid Drugs 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 229930003949 flavanone Natural products 0.000 claims description 3
- 150000002207 flavanone derivatives Chemical class 0.000 claims description 3
- 235000011981 flavanones Nutrition 0.000 claims description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000011949 flavones Nutrition 0.000 claims description 3
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims description 3
- 150000007946 flavonol Chemical class 0.000 claims description 3
- 235000011957 flavonols Nutrition 0.000 claims description 3
- 238000005373 pervaporation Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 claims description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- KYXHKHDZJSDWEF-LHLOQNFPSA-N CCCCCCC1=C(CCCCCC)C(\C=C\CCCCCCCC(O)=O)C(CCCCCCCC(O)=O)CC1 Chemical compound CCCCCCC1=C(CCCCCC)C(\C=C\CCCCCCCC(O)=O)C(CCCCCCCC(O)=O)CC1 KYXHKHDZJSDWEF-LHLOQNFPSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 2
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 claims description 2
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 claims description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 2
- 235000010208 anthocyanin Nutrition 0.000 claims description 2
- 229930002877 anthocyanin Natural products 0.000 claims description 2
- 239000004410 anthocyanin Substances 0.000 claims description 2
- 150000004636 anthocyanins Chemical class 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N caffeic acid Chemical compound OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 2
- 235000005513 chalcones Nutrition 0.000 claims description 2
- 235000013985 cinnamic acid Nutrition 0.000 claims description 2
- 229930016911 cinnamic acid Natural products 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 235000001785 ferulic acid Nutrition 0.000 claims description 2
- 229940114124 ferulic acid Drugs 0.000 claims description 2
- 235000011987 flavanols Nutrition 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 229940074391 gallic acid Drugs 0.000 claims description 2
- 235000004515 gallic acid Nutrition 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical group 0.000 claims description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 2
- 235000008696 isoflavones Nutrition 0.000 claims description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 claims 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims 1
- 238000013375 chromatographic separation Methods 0.000 claims 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims 1
- 239000006193 liquid solution Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 150000002214 flavonoid derivatives Chemical class 0.000 abstract description 8
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 description 22
- 229960004555 rutoside Drugs 0.000 description 22
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 21
- 230000010933 acylation Effects 0.000 description 21
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 21
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 21
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 21
- 235000005493 rutin Nutrition 0.000 description 21
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 20
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 17
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229940093496 esculin Drugs 0.000 description 17
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 17
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 16
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- 239000000758 substrate Substances 0.000 description 13
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 description 12
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 10
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- 238000006911 enzymatic reaction Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000005639 Lauric acid Substances 0.000 description 5
- 241001661345 Moesziomyces antarcticus Species 0.000 description 5
- 108010084311 Novozyme 435 Proteins 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 3
- 238000010923 batch production Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229940025878 hesperidin Drugs 0.000 description 3
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 238000000622 liquid--liquid extraction Methods 0.000 description 3
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011403 purification operation Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical group N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 2
- 239000012808 vapor phase Substances 0.000 description 2
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 229930013915 (+)-catechin Natural products 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CDPKJZJVTHSESZ-UHFFFAOYSA-N 4-chlorophenylacetic acid Chemical compound OC(=O)CC1=CC=C(Cl)C=C1 CDPKJZJVTHSESZ-UHFFFAOYSA-N 0.000 description 1
- BYHDDXPKOZIZRV-UHFFFAOYSA-N 5-phenylpentanoic acid Chemical compound OC(=O)CCCCC1=CC=CC=C1 BYHDDXPKOZIZRV-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- PTNJRKBWIYNFSY-UHFFFAOYSA-N Lirinin-O-methyl-ether Natural products COc1ccc-2c(CC3N(C)CCc4cc(OC)c(OC)c-2c34)c1 PTNJRKBWIYNFSY-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000187418 Streptomyces rochei Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LQSNPVIQIPKOGP-UHFFFAOYSA-N UNPD159785 Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O LQSNPVIQIPKOGP-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000002792 antioxidant assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- PFTAWBLQPZVEMU-UHFFFAOYSA-N catechin Chemical compound OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- PLAPMLGJVGLZOV-VPRICQMDSA-N orientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-VPRICQMDSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- FTBUKOLPOATXGV-UHFFFAOYSA-N propyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCC FTBUKOLPOATXGV-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037370 skin discoloration Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 150000007964 xanthones Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Definitions
- the invention is in the field of phyto- and biochemistry and relates to a process for the enzymatic production of flavonoid derivatives which are used in the food sector, in cosmetics and in pharmaceutical preparations.
- flavonoids have been well known for many years. By trapping various oxidizing species, they prevent oxidative damage to biomolecules such as DNA, lipids and proteins. In antioxidant assays, some flavonoids are more effective than nitamines C and E. In addition to this main property, several other biological effects have been demonstrated, including inhibiting the action of enzymes and the proliferation of animal cells, viruses and bacteria. They also have an effect on the vascular system and a strong antioxidant capacity.
- flavonoids Because of their skin-protecting and cleansing properties and their effects against aging, against skin discoloration and on the appearance of the skin, flavonoids have also been used as components of cosmetic or dermopharmaceutical compositions. Furthermore, they affect the mechanical properties of the hair.
- the anti-oxidant properties of the flavonoids depend on the molecular principle. Studies of the structure-activity relationship have shown that the antioxidant effect on ortho-hydroxylation on ring B of the molecule, the number of free hydroxyl groups, the presence of a double bond between carbon 2 and 3 in ring C and the presence of a hydroxyl group on carbon 3 ( Figure I) is based.
- Patent WO 09966062 mentions the chemical acylation of flavonoids (quercetin, galangin, (+) - catechin) by fatty acids (lauric acid, butyric acid, acetic acid ...) and a subsequent enzymatic hydrolysis step by means of a Mucor miehei lipase.
- This invention has the same disadvantages as the patent FR2778663 (US6235294). After the first performed acylation reaction, the products formed are polyacylated.
- an enzymatic acylation of flavonoids is carried out using various acids (p-chlorophenylacetic acid, stearic acid, 12-hydroxystearic acid, palmitic acid, palmitic acid, Lauric acid, capric acid, 4-hydroxyphenylacetic acid, 5-phenylvaleric acid, cumaric acid, oleic acid, linoleic acid).
- This patent describes a process in which a high concentration of Candida antarctica (40 g / 1) and, based on the flavonoids, an excess of acyl donor is used. The conversion rate of the substrates is low (10 to 20%).
- the invention relates to a process for the enzymatic synthesis of flavonoid esters and derivatives, in which a) a reaction medium is prepared comprising an organic solvent, a glycosylated flavonoid or aglyconflavonoid, an acyl group donor and an enzymatic catalyst, b) optionally adding further amounts of flavonoid and / or acyl donor during the reaction and c) purifying the esters thus obtained by separating enzymatic particles and the solvent, characterized in that the concentration of water formed during the reaction and / or alcohol is controlled so that it is kept below 150 mM.
- the present invention a process for the selective acylation of glycosylated flavonoids and aglyconflavonoids - leads to the improvement of the flavonoid derivatives with regard to their stability and solubility in various preparations, while their antioxidative properties are retained or improved.
- Another particular advantage achieved by these modified flavonoids is that bifunctional molecules with higher biological effectiveness are formed.
- this method can achieve a significant improvement in terms of the final concentrations of flavonoid esters, the conversion yields (both for the flavonoids and the acyl donor originally present) and in particular the productivity, while the complicated, elaborate purification operations after synthesis can be reduced.
- R ' represents a Cl-C4-alkyl group, preferably a Cl-C2-alkyl group.
- This process is characterized in that the reaction medium is first dewatered is used to remove any water present before the start of the reaction, and the water or alcohol formed during the reaction is removed online.
- Water and / or alcohol are kept at concentrations which are suitable for the solvents and substrates used, preferably at concentrations below 150 mM, particularly preferably below 100 mM.
- the process is suitable for a variety of aglycon flavonoids and glycosylated flavonoids, and the conversion yields achieved with this mild enzymatic process are above those obtained so far: in the range of 50 to 99%.
- the enzymatic synthesis is carried out under milder conditions than the chemical syntheses, avoiding the use of toxic solvents such as pyridine, benzene and THF, high temperatures and the accumulation of by-products such as salts or flavonoid degradation products, which would require additional purification steps.
- this method can achieve a significant improvement in terms of the final concentrations of flavonoid esters, the conversion yields (for both the flavonoids and the acyl donor originally present) and, in particular, the productivity, while the complicated, expensive purification operations after the Synthesis can be reduced.
- a difference between the method according to the invention and the known methods of the prior art is the way in which the enzymatic reaction is carried out, which enables considerably higher yields, and the large number of different flavonoids that can be used (both glycosylated forms and aglycon forms) ,
- the main aim of the invention is to reduce all of the above-mentioned disadvantages of existing acylation methods and to propose a method for the enzymatic synthesis of flavonoid esters which, compared to the known methods mentioned above, offers a significant improvement in terms of the final concentrations of flavonoid esters, the conversion yields (both for the flavonoids as well as the originally existing acyl donor) and in particular the productivity, while the complicated, expensive purification operations after the synthesis are reduced.
- the invention relates to a process for the enzymatic synthesis of flavonoid esters, which is characterized in that predetermined amounts of a flavonoid (glycosylated forms and aglycon forms) or flavonoid derivative, an acyl group donor, an organic solvent, in a reactor designed for the formation of a reaction medium it can be the acyl donor and introduces an enzymatic catalyst, under conditions in which the reaction medium can first be dried to a water concentration of less than 150 mM, preferably less than 100 mM and in which the concentration of water formed during the reaction and / or alcohol can be kept below a predetermined point of 150 mM, preferably 100 mM.
- This predetermined point is met by on-line removal of the water and / or alcohol formed by adsorption on molecular sieves, by distillation or by pervaporation.
- This reaction can be carried out in the batch process or also in the fed-batch process with one or more substrates.
- the molar ratio of flavonoid to acyl donor can be kept constant during the reaction by means of a suitable substrate addition profile. It is thus possible to control how the composition of the reaction medium develops over time, and thus to direct the enzymatic reaction towards maximum production of mono- or multiacylated compounds and at the same time to limit interfering reactions.
- the flavonoid esters thus obtained are finally purified by separating at least enzymatic particles (for example by decanting, filtering or centrifuging) and the solvent (for example by evaporation, distillation or membrane filtration).
- the reaction is carried out according to the invention in such a way that the inhibition or deactivation of the enzyme reaction which is observed in the presence of high concentrations of flavonoids, acyl donors or water accumulations is initially restricted.
- the substrates can be fed gradually in a controlled manner as the reaction proceeds, thereby avoiding reaching concentrations that would inhibit the enzyme reaction.
- the reaction can be carried out so that the flavonoid: acyl donor molar ratio of 0.01 to 20, preferably from 0.02 to 10.
- the flavonoid: acyl donor molar ratio of 0.01 to 20, preferably from 0.02 to 10.
- the molar ratio can be kept constant during the reaction or can be varied in a controlled manner, so that it runs through a defined variation profile over time, but is nevertheless in the above-mentioned range of values throughout the reaction .
- the synthesis reaction can be optimized by temporarily or continuously withdrawing at least one component of the reaction medium. The component (s) withdrawn may possibly be returned to the reactor after fractionation.
- the reaction vessel or the reactor used for carrying out the process according to the invention is preferably provided with devices for controlling the temperature, the water and / or alcohol content and the pressure, with devices for adding reagents and with devices for withdrawing products.
- the temperature is advantageously set to 20-100 ° C. and the partial pressure above the reaction medium is advantageously set to 10 mbar (10 3 Pa) to 1000 mbar (10 5 Pa), starting from one to a concentration of less than 150 mM , preferably below 100 mM set initial water content, the amount of water and / or alcohol is kept below 150 mM, preferably below 100 mM and the reaction medium is advantageously stirred gently.
- aglycon flavonoid or glycosylated flavonoid or flavonoid derivative used in the invention can be any compound selected from the group consisting of chalcon, flavon, flavanol, anthocyanin and flavanone, flavonol, coumarin, isoflavones and xanthones.
- the acyl donor compound is selected from known fatty acids or their methyl, ethyl, propyl or butyl esters.
- This fatty acid is preferably selected from that of a straight-chain or branched aliphatic acid, saturated, unsaturated or cyclic, having up to 22 carbon atoms, optionally substituted by one or more substituents, from that of hydroxyl, amino, mercapto, halogen and alkyl-SS-alkyl existing Grappe, for example palmitic acid, 16-hydroxyhexadecanoic acid, 12-hydroxystearic acid, 11-mercaptoundecanoic acid, thioctanoic acid or quinic acid, straight-chain or branched aliphatic diacids, saturated or unsaturated, with up to 22 carbon atoms, for example hexadecanedioic acid or azelaic acid, and an aryl aliphatic acid and an aryl aliphatic acid dimeric acid,
- the reaction can be carried out with the acyl donor as solvent or in a suitable solvent, which can be any organic compound or any mixture of organic compounds in which the selected flavonoids or flavonoid derivatives and acyl donors are wholly or partly solubilized ,
- the solvent (s) is selected in particular from the following substances: propan-2-ol, butan-2-ol, isobutanol, acetone, propanone, butanone, pentan-2-one, 1,2-ethanediol, 2,3-butanediol , Dioxane, acetonitrile, 2-methylbutan-2-ol, tert-butanol, 2-methylpropanol and 4- Hydroxy-2-methylpentanone, aliphatic hydrocarbons such as heptane, hexane or a mixture of two or more of these solvents.
- the enzymatic catalyst used must of course effect and promote the transfer of an acyl group from an acyl donor to a flavonoid or flavonoid derivative and is advantageously a protease or lipase, e.g. from Candida antarctica, Rhizomucor miehei, Candida cylindracea, Rhizopus arrhizus, preferably immobilized on a support.
- a protease or lipase e.g. from Candida antarctica, Rhizomucor miehei, Candida cylindracea, Rhizopus arrhizus, preferably immobilized on a support.
- the reactor first contains the solvent, the total amount of flavonoids (generally from 1 g / 1 to 200 g / 1) required to obtain the desired final amount of modified flavonoids and the amount of free acid as Acyl donor, which corresponds to the molar ratio (of dissolved flavonoid / acyl donor) originally required (generally from 0.01 to 20).
- the medium is brought to a temperature of 20-100 ° C., preferably 40-80 ° C.
- the reactor first contains the solvent, the total amount of flavonoids (in generally from 1 g / 1 to 200 g / 1), which is required to obtain the desired final amount of modified flavonoids, and the amount of free acid as acyl donor, which corresponds to the originally required molar ratio (of dissolved flavonoid / acyl donor) (im generally from 0.01 to 20).
- the medium is brought under vacuum (10-500 mbar, preferably 50-250 mbar) to a temperature of 20-100 ° C., preferably 40-80 ° C. , heated, and the steam mixture produced is dried in a column filled with molecular sieves and then condensed and returned to the reactor. If necessary, the condensate is led back through a second column filled with molecular sieves. Then the enzyme is added in soluble or immobilized form (from 1 g / 1 to 100 g / 1, preferably from 5 g / 1 to 20 g / 1). During the course of the reaction, solvent is added so that part of the solvent is evaporated off through a column with molecular sieves. The water is removed by exchange in the vapor phase. The steam is condensed and collected in a collecting container.
- acyl donor is added online in such an amount per unit of time during the reaction that the molar ratio (of dissolved flavonoid / acyl donor) is kept at the required value.
- the acyl donor is added at a rate which corresponds to the rate of its consumption in the reaction; this rate of consumption can be determined by a preparatory kinetic examination of the enzyme reaction used.
- the amount of acyl donor added per unit time during the reaction is generally from 0.01 to 10 grams of acyl donor per hour per gram of enzyme catalyst in the reactor.
- the synthesis process can also be carried out with the addition of flavonoids and solvents.
- the reactor first contains the solvent, the total amount of free acid as acyl donor (generally from 1 g / 1 to 500 g / 1) required to obtain the desired final amount of modified flavonoids and the amount of Flavonoid, which corresponds to the molar ratio (of dissolved flavonoid acyl donor) originally required (generally from 1 g / 1 to 200 g / 1).
- the medium is vacuum (10-500 mbar, preferably 50- 250 mbar) to a temperature of 20-100 ° C, preferably 40-80 ° C, and the steam mixture generated is dried in a column filled with molecular sieves and then condensed and returned to the reactor. If necessary, the condensate is recirculated through a second column filled with molecular sieves. Then the enzyme is added in soluble or immobilized form (from 1 g / 1 to 100 g / 1, preferably from 5 g / 1 to 20 g / 1).
- solvent is added and a vacuum is applied, so that part of the solvent and the water formed are evaporated off.
- the amount of evaporation is adjusted by controlling the vacuum and the temperature accordingly.
- the vapors formed are passed over a column filled with molecular sieves.
- the water is removed by contact with the molecular sieves.
- the steam is condensed and collected in a collecting tank, in order to be subsequently returned to the reactor.
- anhydrous solvent is added during the reaction to compensate for evaporation losses and to keep the amount of solvent relatively constant.
- flavonoid is added in an amount per unit of time such that the molar ratio (of dissolved flavonoid / acyl donor) is kept at the required value.
- the flavonoid is added at a rate which corresponds to the rate of its consumption in the reaction; this rate of consumption can be determined by a preparatory kinetic examination of the enzyme reaction used.
- the amount of flavonoid added per unit time during the reaction is generally from 0.01 to 10 grams of flavonoid per hour per gram of enzyme catalyst in the reactor.
- the synthesis process can also be carried out with the addition of flavonoid, acyl donor and solvent.
- the reactor first contains the solvent, a variable concentration of flavonoid (preferably higher than the solubility of the flavonoid in the solvent) and the amount of free acid as acyl donor, which corresponds to the molar ratio (of dissolved flavonoid / acyl donor) originally required.
- the medium is brought under vacuum (10-500 mbar, preferably 50-250 mbar) to a temperature of 20-100 ° C., preferably 40- 80 ° C, heated, and the steam mixture generated is dried in a column filled with molecular sieves and then condensed and returned to the reactor. If necessary, the condensate is returned via a second column filled with molecular sieves. Then the enzyme is added in soluble or immobilized form (from 1 g / 1 to 100 g / 1, preferably from 5 g / 1 to 20 g / 1).
- solvents are added and a vacuum in the range of 10-500 mbar, preferably 100-250 mbar, is applied.
- a vacuum in the range of 10-500 mbar, preferably 100-250 mbar.
- the vapors formed are passed over a column with molecular sieves.
- the steam is condensed and collected in a collecting container.
- anhydrous solvent is added during the reaction to compensate for evaporation losses and to keep the amount of solvent relatively constant.
- flavonoid is added in an amount per unit of time such that the molar ratio (of dissolved flavonoid / acyl donor) is kept at the required value.
- flavonoid and acyl donor are added in amounts per unit of time, each corresponding to the rate at which they are consumed in the reaction; these consumption rates can be determined by a preparatory kinetic examination of the enzyme reaction used.
- the continuous synthesis process can alternatively be carried out with the addition and removal of flavonoid, acyl donor and / or solvent and possibly enzyme catalyst.
- the reactor first contains the solvent, a variable concentration of flavonoid (preferably higher than the solubility of the flavonoid in the solvent) and the amount of free acid as acyl donor, which corresponds to the molar ratio (of dissolved flavonoid / acyl donor) originally required.
- the medium is brought under vacuum (10-500 mbar, preferably 50-250 mbar) to a temperature of 20-100 ° C., preferably 40-80 ° C.
- Anhydrous solvent is added during the reaction to compensate for evaporation and stripping losses, and it is still possible to add flavonoid and acyl donor in amounts per unit time to maintain the molar ratio of these two components at the required level.
- the water is removed through molecular sieves as described above. After dewatering, the evaporated solvent is condensed and returned to the reactor --uriick. If it is advantageous to keep this molar ratio constant during the reaction, flavonoid and acyl donor are added in amounts per unit of time which correspond to their respective consumption rates in the reaction and their respective withdrawal rates.
- the reaction is carried out as above, but the free acid as acyl donor is replaced by its methyl, ethyl, propyl or butyl ester, preferably its methyl or ethyl ester.
- the alcohol formed is removed in the same way as above.
- the acyl donor is used as the solvent.
- water and / or alcohol present or present in the medium and / or formed during the reaction is removed through a pervaporation membrane, in the vapor or liquid phase.
- Rutin monopalmitate synthesis was carried out in a 250 ml batch reactor using Candida antarctica lipase (Novozym 435). This is a lipase immobilized on a macroporous acrylic resin. The lipase is supplied with an activity of 7000 PLE xg '1 (propyl laurate synthesis), a water content of 1-2% by weight and an enzymatic protein content in the range between 1 and 10% by weight.
- PLE xg '1 propyl laurate synthesis
- a water content of 1-2% by weight a water content of 1-2% by weight
- an enzymatic protein content in the range between 1 and 10% by weight.
- 0.75 g (1.2 mmol) of rutin 0.75 g (1.2 mmol) of rutin, 0.315 g (1.2 mmol) of palmitic acid and 250 ml were tert. -Amyl alcohol used. The medium was heated to 60 ° C.
- This concentration can be varied by adjusting the vacuum and cooling the cooler accordingly.
- the pressures examined fluctuate between 10 and 700 mbar, and the temperature of the cooler between -20 and 5 ° C. With this procedure it is possible to adjust the water concentration in the reactor to between 5 and 400 mM.
- the enzyme was recovered by filtration. The medium was then concentrated by evaporating the solvent. Two extraction systems were used to eliminate substrate residues. A mixture of acetonitrile / heptane (3/5, v / v) was used to remove the palmitic acid, while the rutin was separated by extraction with water / heptane (2/3, v / v).
- HPLC analysis showed that after 48 hours 95% of the acyl donor was used up.
- the hesperidin monopalmitate could be obtained by liquid-liquid extraction using the same purification instructions as above.
- the structure of this hesperidin ester was confirmed by 1 H-NMR analysis.
- Liquid chromatography analysis showed that 80% of the acyl donor was consumed after 48 hours.
- the same purification instructions as above enabled the esculin monopalmitate to be obtained using liquid-liquid extraction.
- the structure of this esculin ester was confirmed by 1H NMR analysis.
- Example 4 An acylation of rutin with lauric acid was carried out in a 27 ml reactor. Rutin (100 mg, 0.16 mmol) and lauric acid (20 mg, 0.10 mol) were in 20 ml of dried tert-amyl alcohol at 60 ° C. solved. A controlled water content in the reaction medium was adjusted to below 100 mM by adding molecular sieves (4 g). The esterification reaction was started by adding 0.2 g of Candida antartica lipase (Novozym 435). The HPLC analysis showed that the conversion of rutin to the monoester was 76%.
- Rutin (8, 13 mmol) and dodecanedioic acid (0.3 g, 1.3 mmol) were dissolved in 200 ml of tert-amyl alcohol and heated to 60 ° C. under a vacuum of 150-200 mbars). The vapors formed are passed over a column filled with molecular sieves and recovered. In this way, a low water content of less than 100 mm was achieved in the reactor after a few hours. 2 g of Candida antarctica ipase (Novozym 435) were added.
- the cleaning method of the liquid-liquid extraction according to Example 1 enabled the recovery of hexadecanedioyl rutin (monoester).
- the structure of the product was confirmed by 1H-NMR analysis.
- Esculin was reacted with thioctanoic acid in a 250 ml reactor.
- Esculin (0.87g, 2.5mmol) and thioctanoic acid (1.23g, 6mmol) were dissolved in 250 ml of tert-amyl alcohol and heated to 60 ° C under vacuum (150-200 mbars). The vapors formed are passed over a column filled with molecular sieves and recovered. In this way, a low water content of less than 100 mm was achieved in the reactor after 21 hours. 2.5 g of Candida antarctica lipase (Novozym 435) was added. After 70 hours, 50% of the esculin had been converted (HPLC analysis).
- the enzyme was filtered and the reaction medium was concentrated by evaporating the solvent.
- a mixture of water / heptane / acetonitrile (2/3 / 0.4, v / v / v) was used for extraction, and the ester was then obtained by extraction with dichloromethane. The structure of the ester was verified by 1H NMR.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03812154A EP1567655A2 (fr) | 2002-12-03 | 2003-11-22 | Production enzymatique de derives de flavonoides acyles |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02292969 | 2002-12-03 | ||
| EP02292969A EP1426445A1 (fr) | 2002-12-03 | 2002-12-03 | Préparation de dérivés de flavonoides |
| PCT/EP2003/013143 WO2004050889A2 (fr) | 2002-12-03 | 2003-11-22 | Production de derives de flavonoides |
| EP03812154A EP1567655A2 (fr) | 2002-12-03 | 2003-11-22 | Production enzymatique de derives de flavonoides acyles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1567655A2 true EP1567655A2 (fr) | 2005-08-31 |
Family
ID=32309490
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02292969A Withdrawn EP1426445A1 (fr) | 2002-12-03 | 2002-12-03 | Préparation de dérivés de flavonoides |
| EP03812154A Withdrawn EP1567655A2 (fr) | 2002-12-03 | 2003-11-22 | Production enzymatique de derives de flavonoides acyles |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02292969A Withdrawn EP1426445A1 (fr) | 2002-12-03 | 2002-12-03 | Préparation de dérivés de flavonoides |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060115880A1 (fr) |
| EP (2) | EP1426445A1 (fr) |
| JP (1) | JP2006508654A (fr) |
| KR (1) | KR20050085377A (fr) |
| WO (1) | WO2004050889A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110699397A (zh) * | 2019-09-26 | 2020-01-17 | 湖南华诚生物资源股份有限公司 | 一种连续酶促酰化花青素的方法 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070184098A1 (en) * | 2003-06-20 | 2007-08-09 | Philippe Moussou | Esters of flavonoids with w-substituted c6-c22 fatty acids |
| US7807718B2 (en) * | 2006-06-30 | 2010-10-05 | Sami A. Hashim | Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose |
| US7825587B2 (en) * | 2006-08-31 | 2010-11-02 | Universal Display Corporation | Charge transporting layer for organic electroluminescent device |
| US20090280429A1 (en) * | 2008-05-08 | 2009-11-12 | Xerox Corporation | Polyester synthesis |
| JP2010233566A (ja) * | 2009-03-12 | 2010-10-21 | Nisshin Oillio Group Ltd | 糖及び/又は糖アルコールのカルボン酸モノエステルの製造方法 |
| CN111304265B (zh) * | 2020-02-25 | 2021-03-02 | 暨南大学 | 一种油溶性黑豆皮花色苷酰化产物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3165279B2 (ja) * | 1993-03-29 | 2001-05-14 | 三井農林株式会社 | 3−アシル化カテキンを含有する油溶性抗酸化剤 |
| FR2778663B1 (fr) * | 1998-05-15 | 2001-05-18 | Coletica | Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire |
| DE10019235A1 (de) * | 2000-04-18 | 2001-10-31 | Henkel Kgaa | Neue Flavonglykosid-Derivate für den Einsatz in Kosmetika, Pharmazeutika und Ernährung |
| US20030170186A1 (en) * | 2000-04-18 | 2003-09-11 | Bernadette Geers | Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition |
-
2002
- 2002-12-03 EP EP02292969A patent/EP1426445A1/fr not_active Withdrawn
-
2003
- 2003-11-22 KR KR1020057010187A patent/KR20050085377A/ko not_active Withdrawn
- 2003-11-22 US US10/537,627 patent/US20060115880A1/en not_active Abandoned
- 2003-11-22 JP JP2004556169A patent/JP2006508654A/ja not_active Withdrawn
- 2003-11-22 WO PCT/EP2003/013143 patent/WO2004050889A2/fr not_active Ceased
- 2003-11-22 EP EP03812154A patent/EP1567655A2/fr not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004050889A2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110699397A (zh) * | 2019-09-26 | 2020-01-17 | 湖南华诚生物资源股份有限公司 | 一种连续酶促酰化花青素的方法 |
| CN110699397B (zh) * | 2019-09-26 | 2021-06-29 | 湖南华诚生物资源股份有限公司 | 一种连续酶促酰化花青素的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1426445A1 (fr) | 2004-06-09 |
| WO2004050889A3 (fr) | 2004-08-12 |
| KR20050085377A (ko) | 2005-08-29 |
| US20060115880A1 (en) | 2006-06-01 |
| WO2004050889A2 (fr) | 2004-06-17 |
| JP2006508654A (ja) | 2006-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60001173T2 (de) | Verfahren zum extrahieren und reinigung von paclitaxel aus natürlicher quelle | |
| DE60120685T2 (de) | Verfahren zur herstellung von dihydroxyestern und ihren derivaten | |
| EP0618203A1 (fr) | O-acylés catechins et procédé pour leur préparation | |
| DE69925459T2 (de) | Verfahren zur herstellung von hochreinen hmg-coa reductase inhibitoren | |
| Cao et al. | Lipase‐catalyzed solid phase synthesis of sugar esters | |
| EP1567655A2 (fr) | Production enzymatique de derives de flavonoides acyles | |
| EP1582594A2 (fr) | Procédé enzymatique amélioré de préparation de triglycérides d'acides gras polyinsaturés | |
| DE3784853T2 (de) | Verfahren zur herstellung von carbonsaeureestern. | |
| DE69834582T2 (de) | Biokatalytisches verfahren für die herstellung von 3-o-acyl-flavonoiden | |
| WO2003008369A1 (fr) | Procede de fabrication d'esters d'acide citrique | |
| CH646966A5 (de) | Die cholesterinbiosynthese hemmende verbindungen, ihre herstellung und verwendung. | |
| DE2834117C2 (fr) | ||
| CN1030072C (zh) | 用溶剂结晶法分离单脂肪酸甘油酯的工艺 | |
| DE19753789A1 (de) | Verfahren zur selektiven Veresterung von Polyolen | |
| EP1175500B1 (fr) | Procede d'esterification selective de polyols | |
| EP2906708B1 (fr) | Procédé de synthèse enzymatique d'esters d'acides gras à trois étapes | |
| Ohya et al. | Sucrose esters from the surface lipids of Petunia hybrida | |
| Yan | Enzymatic production of sugar fatty acid esters | |
| DE60216296T2 (de) | Biologische vorstufen für die perkutane verabreichung | |
| EP0359042A2 (fr) | Procédé d'isolation d'acides 2-kéto-polyhydroxy-C6-carboxyliques, notamment l'acide 2-kéto-L-gulonique, d'un bouillon de fermentation aqueux | |
| CH667654A5 (de) | Ascorbinsaeurederivate. | |
| JP2779774B2 (ja) | ステリルグリコシドの選択的アシル化方法 | |
| DE69026053T2 (de) | Verfahren zur Herstellung von optisch-aktiven Hydroxyestern | |
| RU2078130C1 (ru) | Способ получения концентрата этиловых эфиров полиненасыщенных высших жирных кислот | |
| DE19626943A1 (de) | Enzymkatalytisches Verfahren zur Herstellung von Monocarbonsäureestern der Mono-, Di- oder Oligosaccharide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20050525 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: COGNIS FRANCE, S.A.S. |
|
| RBV | Designated contracting states (corrected) |
Designated state(s): DE ES FR GB IT |
|
| 17Q | First examination report despatched |
Effective date: 20070507 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20070918 |